Beneficial Effect of Adjunctive Azithromycin in Treatment of Mucoid Pseudomonas aeruginosa Pneumonia in the Murine Model

While a time-kill methodology noted no appreciable improvement in bactericidal activity with the addition of azithromycin (AZM) to a ceftazidime (CAZ) regimen, data from the murine pneumonia model showed that the addition of AZM significantly improved survival compared to treatment with CAZ alone. T...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Nicolau, David P., Banevicius, Mary Anne, Nightingale, Charles H., Quintiliani, Richard
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1999
Sujets:	Experimental Therapeutics
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89611/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10582906/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.12.3033
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!